A multicenter, randomized, double-blind, placebo-control

Project: Research project

Project Details

Description

A multicenter, randomized, double-blind, placebo-controlled phase III trial of tecemotide versus placebo in subject with completed concurrent chemo-radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)
StatusFinished
Effective start/end date1/28/149/30/14

Funding

  • EMD Serono, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.